CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Grund Nicholas Chief Commercial Officer | Grant or award · Stock Option (Right to buy) 10b5-1 | +292,300 | 292,300 | ||
| 2025-01-31 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award | +194,900 | 544,900 | ||
| 2025-01-31 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award · Stock Option (Right to buy) | +292,300 | 292,300 | ||
| 2025-01-17 | FRIESON RON Director | Option exercise | +20,100 | $0.45 | $9K | 93,800 |
| 2025-01-17 | FRIESON RON Director | Option exercise · Stock Option (Right to buy) | −20,100 | 0 | ||
| 2024-06-28 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award | +350,000 | 350,000 | ||
| 2024-06-28 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Grant or award · Stock Option (Right to buy) | +500,000 | 500,000 | ||
| 2024-06-06 | Wolf Myles Director | Grant or award | +30,000 | 97,681 | ||
| 2024-06-06 | Wolf Myles Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2024-06-06 | Smith Cynthia Director | Grant or award | +30,000 | 125,233 | ||
| 2024-06-06 | Smith Cynthia Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2024-06-06 | ROGERS MICHAEL W Director | Grant or award | +30,000 | 126,029 | ||
| 2024-06-06 | ROGERS MICHAEL W Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2024-06-06 | GILMAN STEVEN C Director | Grant or award | +30,000 | 117,130 | ||
| 2024-06-06 | GILMAN STEVEN C Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2024-06-06 | FRIESON RON Director | Grant or award | +30,000 | 73,700 | ||
| 2024-06-06 | FRIESON RON Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2024-06-06 | ZUMWALT LEANNE M Director | Grant or award | +30,000 | 73,700 | ||
| 2024-06-06 | ZUMWALT LEANNE M Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2024-06-06 | ADAMS ADRIAN Director | Grant or award | +30,000 | 164,800 |
Page 5 of 21 · 405 trades